Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro

被引:15
|
作者
Yang, Cheng-Cheng [1 ]
Zheng, Xiang [1 ]
Liu, Teng-Hui [1 ]
Wang, Chen-Chen [1 ]
Tang, Peng-Fei [1 ]
Chen, Zhe [1 ]
Zhang, Bo-Wen [1 ]
Fang, Ping [1 ]
Hu, Guo-Xin [1 ]
Cai, Jian-Ping [2 ,3 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China
关键词
Allelic variant; amiodarone; CYP3A4; polymorphisms; desethylamiodarone; drug metabolism; GENETIC POLYMORPHISMS; N-DEETHYLATION; IDENTIFICATION; PHARMACOKINETICS; VARIABILITY;
D O I
10.1080/00498254.2017.1414971
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1.Cytochrome P450 3A4 (CYP3A4) is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants reported previously. Genetic polymorphisms of CYP3A4 can produce a significant effect on the efficacy and safety of some drugs, so the purpose of this study was to clarify the catalytic characteristics of 22 CYP3A4 allelic isoforms, including 6 novel variants in Han Chinese population, on the oxidative metabolism of amiodarone in vitro. 2.Wild-type CYP3A4*1 and other variants expressed by insect cells system were incubated respectively with 10-500 mu M substrate for 40 min at 37 degrees C and terminated at -80 degrees C immediately. Then these samples were treated as required and detected with ultra-performance liquid chromatography-tandem mass spectrometry used to analyze its major metabolite desethylamiodarone. 3.Among the 21 CYP3A4 variants, compared with the wild-type, the intrinsic clearance values (V-max/K-m) of two variants were apparently decreased (11.07 and 2.67% relative clearance) while twelve variants revealed markedly increased values (155.20 similar to 435.96%), and the remaining of seven variants exhibited no significant changes in enzyme activity. 4.This is the first time report describing all these infrequent alleles for amiodarone metabolism, which can provide fundamental data for further clinical studies on CYP3A4 alleles.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [41] Comparative drug metabolism by CYP3A4 and CYP3A5
    Huang, WL
    Lin, YS
    Dai, Y
    Totah, RA
    Calamia, JC
    Thummel, KE
    DRUG METABOLISM REVIEWS, 2003, 35 : 187 - 187
  • [42] IN VITRO METABOLISM OF DOXAPRAM AND ITS ACTIVE METABOLITE KETODOXAPRAM BY CYP3A4/5
    Ohno, Hitoshi
    Kamada, Noboru
    Endo, Takuro
    Murakami, Makoto
    Kobayashi, Mamoru
    DRUG METABOLISM REVIEWS, 2015, 47 : 206 - 207
  • [43] Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy
    Coto, Eliecer
    Tavira, Beatriz
    Marin, Rafael
    Ortega, Francisco
    Lopez-Larrea, Carlos
    Ruiz-Ortega, Marta
    Ortiz, Alberto
    Diaz, Marta
    Corao, Ana I.
    Alonso, Belen
    Alvarez, Victoria
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) : 576 - 579
  • [44] Effect of NIPRISANA® on CYP3A4 activity in vitro
    Adzu, Bulus
    Masimirembwa, Collen
    Mustapha, Kudirat Bola
    Thelingwani, Roslyn
    Kirim, Rukaiyatu Abdullahi
    Gamaniel, Karniyus Shingu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (01) : 115 - 118
  • [45] Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro:: Effect of fibrates and rifampicin
    Kajosaari, LI
    Laitila, J
    Neuvonen, PJ
    Backman, JT
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 97 (04) : 249 - 256
  • [46] Effect of NIPRISAN® on CYP3A4 activity in vitro
    Bulus Adzu
    Collen Masimirembwa
    Kudirat Bola Mustapha
    Roslyn Thelingwani
    Rukaiyatu Abdullahi Kirim
    Karniyus Shingu Gamaniel
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 115 - 118
  • [47] Time-dependent inhibition of CYP3A4-mediated midazolam metabolism by macrolide antibiotics in CYP3A4 genetic variants: Comparison with testosterone metabolism
    Akiyoshi, Takeshi
    Naitou, Rina
    Imaoka, Ayuko
    Miyazaki, Mitsue
    Guengerich, F. Peter
    Nakamura, Katsunori
    Yamamoto, Koujiro
    Ohtani, Hisakazu
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (12) : 745 - 752
  • [48] Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism
    Yuan, Ling-Jing
    Li, Xiang-Yu
    Ni, Jin-Huan
    Wang, Jing
    Xu, Xiao-Yu
    Luo, Jian-Chao
    Zhou, Qi
    Hu, Guo-Xin
    Cai, Jian-Ping
    Qian, Jian-Chang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 475
  • [49] Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism
    Tang, Peng-fei
    Zheng, Xiang
    Hu, Xiao-xia
    Yang, Cheng-cheng
    Chen, Zhe
    Qian, Jian-chang
    Cai, Jian-ping
    Hu, Guo-xin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5129 - 5141
  • [50] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13